Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can detect signature features of progressive supranuclear palsy (PSP), a rare ...

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression ...

Civil rights activist Rev. Jesse Jackson has been hospitalised and is managing neurological disease progressive supranuclear palsy, or PSP, announced the Rainbow PUSH Coalition. The 84-year-old is ...